Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CardioGenesis Data From 900 Additional Patients May Push PMR Over Top

This article was originally published in The Gray Sheet

Executive Summary

CardioGenesis is hoping that its PMR percutaneous myocardial revascularization system can be approved by early 2003 without a second panel review

You may also be interested in...



Cardiogenesis Starts Clinical Trial For Its Pearl Robotic TMR System

Cardiogenesis is developing a minimally-invasive transmyocardial revascularization (TMR) procedure for use on its Pearl 5.0 robotic laser delivery system, which is expected to receive FDA clearance within a few months

Cardiogenesis Starts Clinical Trial For Its Pearl Robotic TMR System

Cardiogenesis is developing a minimally-invasive transmyocardial revascularization (TMR) procedure for use on its Pearl 5.0 robotic laser delivery system, which is expected to receive FDA clearance within a few months

CardioGenesis Prepares For New Trial Of Percutaneous Laser Angina Device

CardioGenesis credits the recent regulatory progress of its Axcis laser percutaneous myocardial channeling (PMC) system to the contributions of Syncardia CEO Marvin Slepian, MD

Related Content

UsernamePublicRestriction

Register

MT016819

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel